Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a magnetic helmet help stroke survivors learn to move again?

NCT ID NCT05467657

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tested whether applying magnetic pulses to the brain's sensory area could help stroke survivors learn movements better. Twenty people who had a stroke at least three months ago received the stimulation while researchers measured brain activity and motor responses. The goal was to see if this approach might enhance motor learning, but the study was exploratory and not designed to prove a treatment works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS) device
What this could lead to
If it works, this could point toward a new way to help stroke survivors regain movement by boosting brain activity in the sensory area.
What could go wrong
This is a very small, early-stage study with only 20 participants and no control group. The results may not apply to all stroke survivors, and the effect on real-world movement is unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Nov 2023

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having suffered an ischaemic or haemorrhagic stroke with more than 3 months of evolution * Presenting a score \>21 points on the Mini-mental State Examination scale. Exclusion Criteria: * Severe impairment of upper limb motor function (\<15 points on the Fugl-Meyer Assessment Upper Extremity scale) * Any contraindications to rTMS, such as metal implants, history of epileptic seizures or taking medication that lowers the seizure threshold * Previous history of neurological pathology.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Motor learning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neuron Chamberí

    Madrid, Madrid, 28003, Spain

  • Neuron Madrid Rio

    Madrid, Madrid, 28045, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.